# 68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

> **NCT06084767** · NA · UNKNOWN · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Malignant Tumor
- Positron Emission Tomography
- Fibroblast Activation Protein Inhibitor

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-TCR-FAPI PET/CT

## Key facts

- **NCT ID:** NCT06084767
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-05
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06084767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06084767, "68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06084767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*